Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Spectral AI, Inc. (MDAI : NSDQ)

• Company Description    Spectral MD Holdings Ltd. is a predictive AI company focused on medical diagnostics. The Company's DeepView(R) platform is a predictive diagnostic device which offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. Spectral MD Holdings Ltd., formerly known as ROSECLIFF ACQ, is based in DALLAS. Number of Employees: 65

• Price / Volume Information    Yesterday's Closing Price: $2.68 Daily Weekly Monthly 20 Day Moving Average: 595,096 shares Shares Outstanding: 31.82 (millions) Market Capitalization: $85.29 (millions) Beta: 1.16 52 Week High: $3.21 52 Week Low: $1.18 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 48.89% 41.62% 12 Week 88.73% 74.47% Year To Date 88.73% 70.93%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2515 McKinney Avenue Suite 1000 - Dallas,TX 75201 USA ph: 972-499-4934 fax: - ir@spectral-ai.com http://www.spectral-ai.com

• General Corporate Information    Officers Vincent S. Capone - Chief Executive Officer J. Michael DiMaio - Director Richard Cotton - Director Martin Mellish - Director Deepak Sadagopan - Director Peer Information Spectral AI, Inc. (ABMD) Spectral AI, Inc. (DMDS) Spectral AI, Inc. (CPWY.) Spectral AI, Inc. (EQUR) Spectral AI, Inc. (ECIA) Spectral AI, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 84757T105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/11/26 Share - Related Items Shares Outstanding: 31.82 Most Recent Split Date: (:1) Beta: 1.16 Market Capitalization: $85.29 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.14 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.50 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 5.11 EPS Growth vs. Year Ago Period: -200.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -40.50% vs. Previous Quarter: 3.69% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - -72.97 12/31/25 - -35.64 09/30/25 - -27.57 Current Ratio 03/31/26 - 0.75 12/31/25 - 0.94 09/30/25 - 0.85 Quick Ratio 03/31/26 - 0.71 12/31/25 - 0.90 09/30/25 - 0.83 Operating Margin 03/31/26 - -76.97 12/31/25 - -33.70 09/30/25 - -19.08 Net Margin 03/31/26 - -85.58 12/31/25 - -41.11 09/30/25 - -70.64 Pre-Tax Margin 03/31/26 - -83.55 12/31/25 - -38.47 09/30/25 - -69.79 Book Value 03/31/26 - -0.28 12/31/25 - -0.19 09/30/25 - -0.27 Inventory Turnover 03/31/26 - 14.16 12/31/25 - 19.58 09/30/25 - 28.66 Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©